Advances in technology, especially in the field of AI, can significantly relieve the ever-increasing workload of radiologists today. We are continuously striving to make the most out of the countless possibilities AI offers. Therefore, we are about to incorporate multiple AI elements into mint Lesion™ with various partners and an example of this is an upcoming plug-in, with which it will be possible to automatically detect and 3D-segment the prostate in MR T2-weighted images.
The new plug-in, Prostate.Carcinoma.ai from our partner FUSE-AI, will simplify and speed up prostate screenings according to PI-RADS 2.1. At the touch of a button, a full segmentation of the prostate will be calculated within mint Lesion™, including findings of benign or malignant lesions. By using the automatically calculated volume segmentation of the prostate, mint Lesion™ automatically maps the lesions to the prostate lesion scheme, making manual drawings unnecessary.
In the early development phase, the plug-in was made available to Dr. Alexander Cornelius and his team at the Cantonal Hospital Aarau to test and provide user feedback. Dr. Cornelius states: “AI in radiology is the logical consequence of the ongoing developments in recent years to reach a new level of medical and clinical care. For me, even the first results from the Prostate.Carcinoma.ai plug-in in mint Lesion™ were a substantial improvement!“
Fighting prostate cancer with AI and automatic segmentation
Related Resources
Related Resources
Closing the Care Gap by Shaping the Future of Evidence-Based Medicine
Healthcare still lags behind other economic sectors in terms of digitalization. Despite significant advancements in diagnostic and therapeutic…
Supporting Multidisciplinary Approach to Cancer Diagnosis and Therapy
Patients rely on their providers for high-quality care that encompasses the most up-to-date recommendations for diagnosis and therapy. Integrated…
LMU Munich: Prospective study shows the suitability of a semi-automatic approach to assess changes in prostate MRI after prostatic artery embolization
A prospective, monocentric study [1] conducted by Vanessa F. Schmidt and her colleagues at the University Hospital Munich (LMU) evaluated the…